Cervical cancer occurs when abnormal cancer cells develop in the cervix due to exposure to the human papillomavirus (HPV), however not all exposures to HPV cause cervical cancer. Cervical cancer is the second most common type of cancer in women and the most greatly affects the age groups 35-39 and 60-64. It is frequently found in early stages through the use of pap test. Cervical cancer is commonly treated with chemotherapy, radiation, and surgery to remove pelvic lymph nodes with or without the removal of the ovaries and fallopian tubes. In the most severe cases, hysterectomies may be necessary. Many believe that the HPV vaccine protects against the two types of HPV that cause cervical cancer. Stage 1A in cervical cancer is defined by the fact that it can only be seen with a microscope. Stage 1A is divided into 1A1 as well as 1A2 which are separated by different sizes of growth.
Stage Ia Cervical Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Ia Cervical Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 202 products for the study of Stage Ia Cervical Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.